Abstract
While several predictors of an early and sustained response can be identified in the treatment of chronic hepatitis B, no consistently demonstrable predictors of response exist for chronic hepatitis C. As such, guidelines for the treatment of chronic hepatitis C are more complex than those for hepatitis B. The treatment options for chronic hepatitis B and C are outlined and there is speculation on the clinical challenges of the future.
